Piotr Pruszczyk
Overview
Explore the profile of Piotr Pruszczyk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
295
Citations
5788
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Slawek-Szmyt S, Stepniewski J, Kurzyna M, Klaudel J, Kuliczkowski W, Lewandowski M, et al.
Respir Res
. 2025 Mar;
26(1):87.
PMID: 40045310
Background: Data on interventional treatment of intermediate-high (and high-risk pulmonary embolism (PE) are limited. The authors sought to evaluate the safety and efficacy of catheter-directed mechanical aspiration thrombectomy (CDMT) in...
2.
Kurnicka K, Perzanowska-Brzeszkiewicz K, Galecka-Nowak M, Cader T, Dzikowska-Diduch O, Ciurzynski M, et al.
Kardiol Pol
. 2025 Feb;
PMID: 39976497
No abstract available.
3.
Jermakow M, Machowski M, Galecka-Nowak M, Deutsch K, Il A, Imiela A, et al.
J Clin Med
. 2025 Feb;
14(3).
PMID: 39941354
The primary role of a pulmonary embolism response team (PERT) is to support decision-making processes regarding acute pulmonary embolism (PE) patients and provide advanced rescue therapies when needed. Despite a...
4.
Cader T, Karpeta E, Jankowski K, Lisik W, Pruszczyk P, Kurnicka K
Kardiol Pol
. 2025 Jan;
PMID: 39821622
No abstract available.
5.
Luijten D, van den Hout W, Boon G, Barco S, Bogaard H, Delcroix M, et al.
ERJ Open Res
. 2025 Jan;
11(1.
PMID: 39811556
Introduction: Achieving an early diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) in pulmonary embolism (PE) survivors results in better quality of life and survival. Importantly, dedicated follow-up strategies to achieve...
6.
Drozdz J, Morawiec R, Drozd M, Krzesinski P, Wozakowska-Kaplon B, Grabowski M, et al.
Kardiol Pol
. 2025 Jan;
PMID: 39743905
No abstract available.
7.
Dzikowska-Diduch O, Cader T, Jankowski K, Ou-Pokrzewinska A, Sznajder M, Siwiec J, et al.
J Clin Med
. 2024 Nov;
13(22).
PMID: 39598134
: The prevalence of portopulmonary hypertension (PoPH) is relatively low; however, its presence significantly worsens patients' prognosis. When diagnosed, PoPH can be effectively treated, and specific therapies can lead to...
8.
Waligora M, Kurzyna M, Mularek-Kubzdela T, Skoczylas I, Chrzanowski L, Blaszczak P, et al.
Chest
. 2024 Nov;
PMID: 39528108
Background: Current guidelines do not recommend β-blockers in pulmonary arterial hypertension (PAH) unless indicated by comorbidities. However, the evidence regarding the role of β-blockers in PAH is contradictory. Research Question:...
9.
Skonieczny G, Skowronska M, Dolacinska A, Ratajczak B, Sulik P, Doroba O, et al.
Cardiol J
. 2024 Nov;
32(1):1-8.
PMID: 39506902
Background: SARS-CoV-2 infection may lead to myocardial and endothelial damage. The present study sought to characterize the cardiovascular sequel in a large group of consecutive patients admitted for out-patient cardiovascular...
10.
Imiela A, Mikolajczyk T, Pruszczyk P
Arch Immunol Ther Exp (Warsz)
. 2024 Oct;
72(1).
PMID: 39466143
Accumulating data have shown a pathophysiological association between inflammatory pathways and thrombosis. Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and acute pulmonary embolism (APE), is a significant health...